| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 20, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 41.3 | -2,705 | -2.01% | ✓ | $122.1K |
| Jun 11, 2024 | Jun 11, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 45.0 | -1,823 | -1.33% | ✓ | $57.1K |
| May 16, 2024 | May 17, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 45.0 | -2,774 | -1.99% | ✓ | $78.4K |
| Mar 8, 2024 | Mar 13, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 20.0 | -109,601 | -12.60% | ✓ | $2.9M |
| Mar 7, 2024 | Mar 11, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 45.0 | -2,434 | -1.69% | ✓ | $62.9K |
| Feb 29, 2024 | Mar 1, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 35.0 | -28,528 | -4.64% | ✓ | $811.9K |
| Jan 26, 2024 | Jan 26, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 22.5 | -20,000 | -12.22% | ✓ | $490.5K |
| Jan 2, 2024 | Jan 4, 2024 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 30.0 | -31,900 | -5.17% | ✓ | $529.2K |
| Dec 11, 2023 | Dec 12, 2023 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 51.3 | -1,245 | -0.79% | ✓ | $13.3K |
| Sep 18, 2023 | Sep 20, 2023 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 45.0 | -1,261 | -2.04% | ✓ | $11.9K |
| Sep 12, 2023 | Sep 13, 2023 | Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 26.3 | -1,266 | -2.01% | ✗ | $13.2K |
| Jun 12, 2023 | Jun 14, 2023 | Dyne Therapeutics, Inc. | Officer | Sell | 41.3 | -2,259 | -3.45% | ✓ | $28.6K |
| Mar 13, 2023 | Mar 15, 2023 | Dyne Therapeutics, Inc. | Officer | Sell | 41.3 | -2,209 | -3.27% | ✓ | $29.1K |
| Jan 18, 2023 | Jan 23, 2023 | Dyne Therapeutics, Inc. | Officer | Sell | 25.0 | -10,000 | -12.89% | ✓ | $140.3K |
| Jan 9, 2023 | Jan 11, 2023 | Dyne Therapeutics, Inc. | Officer | Sell | 7.5 | -30,150 | -30.84% | ✓ | $348.8K |
| Dec 9, 2022 | Dec 13, 2022 | Dyne Therapeutics, Inc. | Officer | Sell | 90.0 | +39,528 | 67.89% | ✓ | $5.1K |
| Sep 20, 2022 | Sep 21, 2022 | Dyne Therapeutics, Inc. | Officer | Sell | 45.0 | -1,246 | -2.10% | ✓ | $17.1K |
| Sep 15, 2022 | Sep 15, 2022 | Dyne Therapeutics, Inc. | Officer | Sell | 52.5 | -494 | -0.82% | ✓ | $6.9K |
| Jun 14, 2022 | Jun 15, 2022 | Dyne Therapeutics, Inc. | Officer | Sell | 52.5 | -504 | -0.83% | ✓ | $2.5K |
| Mar 11, 2022 | Mar 14, 2022 | Dyne Therapeutics, Inc. | Officer | Sell | 52.5 | -481 | -0.79% | ✓ | $4.2K |
| Sep 20, 2021 | Sep 22, 2021 | Dyne Therapeutics, Inc. | Officer | Sell | 41.3 | -1,274 | -3.45% | ✓ | $20.3K |